HOWL - Werewolf Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.73 0.0 (0.03%)	---	---	0.0 (0.0%)	-0.08 (-4.62%)	0.12 (6.99%)	-0.01 (-0.54%)	-0.01 (-0.54%)

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.4
Diluted EPS:: -0.4
Basic P/E:: -4.3265
Diluted P/E:: -4.3265
RSI(14) 1m:: 0.0
VWAP:: 1.73
RVol:: 0.4919

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	1.77 +0.02 (+1.14%)	Oct 15 18:10
1m	Price decrease 1m	1.71 -0.03 (-1.69%)	Oct 15 15:16
1m	Price decrease 1m	1.71 -0.02 (-1.16%)	Oct 15 15:15
1m	Price increase 1m	1.74 +0.02 (+1.16%)	Oct 15 14:37
1m	Price increase 1m	1.7 +0.02 (+1.19%)	Oct 15 13:29